HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter L Choyke Selected Research

Immune Checkpoint Inhibitors

6/2022Near-Infrared Photoimmunotherapy (NIR-PIT) in Urologic Cancers.
1/2022CD29 targeted near-infrared photoimmunotherapy (NIR-PIT) in the treatment of a pigmented melanoma model.
9/2021Near infrared photoimmunotherapy of cancer; possible clinical applications.
12/2020Increased Immunogenicity of a Minimally Immunogenic Tumor after Cancer-Targeting Near Infrared Photoimmunotherapy.
9/2020Near-Infrared Photoimmunotherapy Combined with CTLA4 Checkpoint Blockade in Syngeneic Mouse Cancer Models.
1/2019Near-Infrared Photoimmunotherapy of Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter L Choyke Research Topics

Disease

284Neoplasms (Cancer)
04/2024 - 01/2002
101Prostatic Neoplasms (Prostate Cancer)
04/2024 - 04/2009
39Neoplasm Metastasis (Metastasis)
10/2023 - 09/2006
23Ovarian Neoplasms (Ovarian Cancer)
11/2018 - 07/2006
10Breast Neoplasms (Breast Cancer)
02/2024 - 05/2004
7Head and Neck Neoplasms (Head and Neck Cancer)
04/2024 - 01/2021
7Hepatocellular Carcinoma (Hepatoma)
10/2023 - 01/2015
6Adenocarcinoma
01/2021 - 11/2007
5Melanoma (Melanoma, Malignant)
02/2024 - 07/2008
4Lymphoma (Lymphomas)
02/2024 - 11/2005
4Lung Neoplasms (Lung Cancer)
02/2024 - 01/2009
4Urinary Bladder Neoplasms (Bladder Cancer)
01/2024 - 10/2017
4Liver Neoplasms (Liver Cancer)
01/2023 - 10/2019
4Infections
01/2020 - 08/2006
4Necrosis
01/2020 - 01/2014
4Carcinoma (Carcinomatosis)
01/2019 - 09/2006
4Renal Cell Carcinoma (Grawitz Tumor)
01/2016 - 05/2004
4Inflammation (Inflammations)
11/2014 - 10/2007
3Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2023 - 10/2011
3Hypoxia (Hypoxemia)
01/2020 - 05/2004
3Kidney Neoplasms (Kidney Cancer)
01/2020 - 01/2002
3Lymphatic Metastasis
01/2016 - 05/2004
3Carcinogenesis
02/2011 - 05/2004

Drug/Important Bio-Agent (IBA)

43Monoclonal AntibodiesIBA
08/2022 - 04/2007
38AntigensIBA
03/2024 - 05/2007
30Prostate-Specific Antigen (Semenogelase)IBA
02/2024 - 04/2007
29AntibodiesIBA
04/2024 - 05/2007
25Coloring Agents (Dyes)IBA
12/2022 - 11/2006
22Proteins (Proteins, Gene)FDA Link
03/2024 - 08/2008
22ErbB Receptors (EGF Receptor)IBA
10/2023 - 04/2007
21Contrast MediaIBA
09/2018 - 03/2002
20Biomarkers (Surrogate Marker)IBA
04/2024 - 01/2006
17LigandsIBA
05/2023 - 07/2006
15Therapeutic UsesIBA
04/2024 - 03/2010
15RhodaminesIBA
11/2018 - 11/2006
14Trastuzumab (Herceptin)FDA Link
01/2021 - 05/2007
14Photosensitizing Agents (Photosensitizers)IBA
03/2016 - 11/2011
13AvidinIBA
12/2011 - 07/2006
12Radioisotopes (Radionuclides)IBA
01/2023 - 04/2007
12Panitumumab (Vectibix)FDA Link
08/2022 - 11/2009
12phthalocyanineIBA
06/2022 - 11/2011
12Fluorescent Dyes (Fluorescent Probes)IBA
11/2018 - 11/2006
102- (3- (1- carboxy- 5- ((6- fluoropyridine- 3- carbonyl)amino)pentyl)ureido)pentanedioic acidIBA
04/2024 - 10/2017
10Galactose (Galactopyranose)FDA LinkGeneric
11/2016 - 09/2007
8Cetuximab (Erbitux)FDA Link
08/2022 - 04/2007
8Indicators and Reagents (Reagents)IBA
10/2017 - 05/2004
7Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
02/2024 - 10/2014
7Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2021 - 02/2009
6Immune Checkpoint InhibitorsIBA
06/2022 - 01/2019
6EnzymesIBA
11/2018 - 08/2013
6ferric oxide (iron oxide)IBA
09/2018 - 07/2011
6LectinsIBA
11/2016 - 07/2006
6GadoliniumIBA
11/2014 - 06/2005
6Dendrimers (Dendrons)IBA
07/2011 - 04/2004
5AndrogensIBA
02/2024 - 01/2019
5Immunoconjugates (Immunoconjugate)IBA
01/2024 - 09/2007
5silicon phthalocyanineIBA
01/2023 - 11/2018
5GlypicansIBA
01/2023 - 01/2015
5AcidsIBA
10/2021 - 04/2007
5Glucose (Dextrose)FDA LinkGeneric
01/2020 - 02/2010
54,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA
01/2019 - 09/2006
5LuciferasesIBA
12/2017 - 08/2012
5Serum AlbuminIBA
11/2016 - 09/2007
4Neoplasm Antigens (Tumor Antigens)IBA
12/2022 - 01/2019
4Immunoglobulin FragmentsIBA
10/2022 - 03/2011
4FluoridesIBA
01/2022 - 11/2018
4Hormones (Hormone)IBA
10/2021 - 01/2010
4Peptides (Polypeptides)IBA
10/2019 - 03/2007
4Immunoglobulin G (IgG)IBA
01/2019 - 04/2014
4Sodium Fluoride (Ossin)FDA Link
06/2018 - 09/2011
4Red Fluorescent ProteinIBA
11/2016 - 11/2007
4GalactosamineIBA
08/2008 - 09/2007
3enzalutamideIBA
02/2024 - 01/2021
3Androgen Receptors (Androgen Receptor)IBA
02/2024 - 08/2017
368Ga-FAPIIBA
11/2023 - 01/2020
3RadiopharmaceuticalsIBA
11/2023 - 12/2015
3Interleukin-15 (Interleukin 15)IBA
10/2023 - 09/2020
3Somatostatin Receptors (Somatostatin Receptor)IBA
01/2023 - 10/2011
3Surface Antigens (Surface Antigen)IBA
10/2022 - 06/2009
3DNA (Deoxyribonucleic Acid)IBA
12/2021 - 01/2019
3VaccinesIBA
01/2020 - 07/2007
3Ferrosoferric Oxide (Magnetite)FDA Link
01/2020 - 07/2015
3Epidermal Growth Factor (EGF)IBA
06/2018 - 11/2007
3Capsules (Microcapsules)IBA
01/2017 - 10/2015
3Fluconazole (Zonal)FDA LinkGeneric
12/2015 - 01/2012
3galactosyl serum albumin-rhodamine greenIBA
03/2014 - 11/2007
3Growth Factor ReceptorsIBA
08/2012 - 03/2009
3neutravidinIBA
01/2009 - 09/2006

Therapy/Procedure

126Therapeutics
04/2024 - 05/2003
26Prostatectomy (Retropubic Prostatectomy)
02/2024 - 11/2011
18Immunotherapy
04/2024 - 01/2013
12Radiotherapy
11/2023 - 01/2014
9Castration
03/2024 - 06/2013
9Drug Therapy (Chemotherapy)
09/2022 - 09/2007
8Lasers (Laser)
10/2022 - 07/2002
5Phototherapy (Light Therapy)
05/2021 - 07/2016
4Aftercare (After-Treatment)
09/2023 - 01/2020
3Operative Time
01/2017 - 10/2002
3Precision Medicine
11/2016 - 03/2012
3Nephrectomy
01/2008 - 10/2002